Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257
Year: 2020
Type: article
Abstract: Background. Metabolic effects following combination antiretroviral therapy (cART) vary by regimen type. Changes in metabolic effects were assessed following cART in the AIDS Clinical Trials Group (ACTG) A5257 study, and correlated with plasma ritonavir trough concentrations (C24).
DOI: 10.17615/mcq6-3a51
Authors: Leavitt, Randi Y., Para, Michael F., Villasis-Keever, Angelina, Brown, Todd T., Ofotokun, Ighovwerha, Godfrey, Catherine, Landovitz, Raphael J., Cohn, Susan E., Na, Lumine H., Currier, Judith S., Sagar, Manish, Aweeka, Francesca, Ribaudo, Heather J., Lennox, Jeffrey L., Patterson, Kristine B., Baugh, Bryan P., Kuritzkes, Daniel R., Mccomsey, Grace A.
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Emergency Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4300529029